Strain-promoted click chemistry boosts microbubbles for targeted ultrasound imaging and cancer chemotherapy

  • Acta Biomater. 2026 Jul:218:510-524. doi: 10.1016/j.actbio.2026.06.005.
Xuanxuan Zhang  1 Yuejie Lu  2 Xiaojin Wu  1 Wei Zhu  1 Rumei Li  1 Qianyun Shan  1 Shangxu Jiang  3 Xiaojun Xia  1 Bin Ying  1 Mingdi Shen  1 Zhikang Xu  1 Shengjun Wang  4 Kai Zhang  5 Jian Chen  6
Affiliations
  • 1. Department of Ultrasound in Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322000, China.
  • 2. Department of General Surgery, Center for Metabolism Research, The Fourth Affiliated Hospital of Zhejiang University School of Medicine and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322000, China.
  • 3. Institute for Nanoscale Science and Technology, College of Science and Engineering, Flinders University, Sturt Road, Bedford Park, South Australia 5042, Australia.
  • 4. School of Engineering, Qinghai Institute of Technology, Xining 810016, China. Electronic address: [email protected].
  • 5. School of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China. Electronic address: [email protected].
  • 6. Department of Ultrasound in Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322000, China; School of Chemistry and Chemical Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China. Electronic address: [email protected].
Abstract

Targeted microbubbles (MBs) have emerged as pivotal dual-functional agents for molecular ultrasound (US) imaging and US-triggered targeted drug delivery. However, the efficacy of traditional ligand-directed MBs is often compromised by the inherent heterogeneity of tumor receptor expression and physiological barriers. Herein, we report a robust targeting platform based on dibenzocyclooctyne-functionalized MBs (MB-DBCO) that leverages metabolic glycoengineering and bioorthogonal strain-promoted azide-alkyne cycloaddition (SPAAC). This strategy decoupled targeting efficiency from genetic receptor expression by pre-installing azide chemical handles onto the tumor cell surface. Our results demonstrate that MB-DBCO provides a stable "chemical anchor" in both 4T1 tumor cells and vascular endothelial cells, significantly enhancing contrast-enhanced ultrasound (CEUS) sensitivity and tumor cell specificity. Crucially, the synergistic combination of SPAAC-mediated covalent tethering and US cavitation-induced sonoporation breaches the endothelial cell barrier and tumor stromal barriers, driving the deep penetration of the paclitaxel (PTX) payload. In vivo studies showed that the MB-DBCO + US treatment leads to profound tumor regression, extensive vascular depletion, and a significantly prolonged survival time in aggressive 4T1 tumor models. This study establishes a modular, chemically-defined, and scalable targeting platform that overcomes the critical biological barriers of solid tumors, offering a promising paradigm for CEUS imaging and US-triggered chemotherapy. STATEMENT OF SIGNIFICANCE: Contrast-enhanced ultrasound (CEUS) imaging and US-triggered targeted chemotherapy efficacy of dual functional microbubbles (MBs) is often compromised by heterogeneous receptor expression and the endothelial cell barrier of solid tumors. This study introduces a modular bioorthogonal platform that decouples tumor targeting from genetic markers by converting metabolic flux into a robust chemical interface for MBs anchoring. We demonstrate that this stable chemical-mechanical coupling enables localized cavitation to physically breach the tumor stroma, providing a scalable and universal framework for CEUS imaging and US-triggered targeted chemotherapy.

Keywords
CEUS imaging; Dual-functional microbubbles; SPAAC; Targeted drug delivery.
Products